Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2025-04-02 Investor Presentation
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司关于召开2024年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2024 annual performance explanation meeting (业绩说明会) to be held on April 14, 2025. It mentions that the company's 2024 annual report will be disclosed on April 11, 2025, and the meeting is intended to discuss the annual results and financial indicators interactively with investors. The document does not contain actual financial data or detailed financial statements but serves as a notice for the upcoming investor meeting related to the annual results. The document length is short (1525 characters) and is clearly an announcement rather than the report or transcript itself. Therefore, it fits best into the category of Investor Presentation (IP) as it is a detailed presentation event for investors focusing on financials and company performance, or possibly AGM Information (AGM-R) if it were an AGM. However, since it is specifically an earnings performance explanation meeting (业绩说明会) and not an AGM, the best fit is Investor Presentation (IP).
2025-04-02 Chinese
深圳普门科技股份有限公司关于签署《投资建设协议》暨对外投资项目进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Pumen Technology Co., Ltd. regarding the signing of an "Investment Construction Agreement" and progress on an external investment project. It details the investment project, the parties involved, the obligations, risks, and the impact on the company. There are no financial statements or detailed financial performance data included. The document is a formal announcement about a capital investment project and its progress, not a financial report or earnings release. It fits the description of a Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes through investment projects.
2025-03-31 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of its controlling subsidiary obtaining a medical device registration certificate issued by the Chongqing Drug Administration. The content focuses on the registration certificate details, product description, impact on the company, and risk warnings. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is a regulatory announcement about a product registration event, which does not fit into financial reports or management changes. It is a regulatory announcement about a corporate event related to product registration, best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2025-03-31 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of a subsidiary obtaining a medical device registration certificate. It includes details about the certificate, its validity, and the expected impact on the company. The document is short (840 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval related to product registration, not a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2025-03-26 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of its controlling subsidiary obtaining a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the registration certificate specifics, product description, and the expected impact on the company. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is an announcement of a regulatory approval related to product registration, which does not fit into financial reports or management changes. It is a regulatory announcement about a product certification, best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2025-03-20 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. about obtaining medical device registration certificates issued by the Guangdong Provincial Drug Administration. It details the registration certificates for three medical diagnostic reagent kits, their intended uses, and the impact on the company. The document is an official announcement of regulatory approval and does not contain financial statements, management discussion, or detailed financial data. It is relatively short (1816 characters) and serves as a regulatory update rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-04 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.